Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for knee pain with bone marrow oedema
ACTRN12609000399291Phase 3Completed
- Sponsor
- Menzies Institute for Medical Research
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of zoledronic acid in knee arthralgia (2 arms), sponsored by Menzies Institute for Medical Research. Primary endpoint: Magnetic resonance imaging assessment of bone marrow lesions. Started Jul 2009; status: completed.
02
Drugs
zoledronic acid
03
Conditions
knee arthralgia
Beyond the preview
Go deeper on ACTRN12609000399291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000399291.